Nuclear Imaging of CNS Diseases in Rodent Models
31 May 2016 | By Charles River
Charles River highlights new kinetic PET imaging and AIF as new tools in our comprehensive portfolio of imaging and associated ex vivo techniques...
List view / Grid view
31 May 2016 | By Charles River
Charles River highlights new kinetic PET imaging and AIF as new tools in our comprehensive portfolio of imaging and associated ex vivo techniques...
3 May 2016 | By Victoria White, Digital Content Producer
Researchers have obtained images of the NMDA receptor in different states. Understanding how NMDA receptors activate is critical in designing new drugs...
28 April 2016 | By Victoria White, Digital Content Producer
Researchers have shown that zinc-oxide nanoparticles can prevent genital herpes virus from entering cells, and help natural immunity to develop...
22 April 2016 | By Victoria White, Digital Content Producer
AstraZeneca has launched an integrated genomics initiative to transform drug discovery and development across its entire research and development pipeline...
22 April 2016 | By SMi Group
SMI Reports (12.04.2016): MedImmune Senior Director for R&D to present keynote address on MED10382 at the 3rd Peptides Conference in London...
13 April 2016 | By Victoria White, Digital Content Producer
The effects of LSD on the human brain have been visualised for the first time and may lead to new treatments for psychiatric disorders...
12 April 2016 | By Caroline Richards, Editor, Drug Target Review
Here, Caroline Richards, Editor of Drug Target Review, discusses the publication and the opportunities available to authors...
21 March 2016 | By Victoria White
The MOZART technique could allow scientists to detect tumours in the skin or see abnormal blood vessels from the early stages of macular degeneration...
Long term success for pharmaceutical businesses depends upon harnessing the best tools available to bring safe and effective medicines to market at a competitive price, and to be truly successful, for such drugs to be first in class.
17 March 2016 | By Merck KGaA
The CellASIC® ONIX2 Microfluidic System for live cell imaging is easy to use and gives researchers precise environmental control over live cells. By providing dynamic control over drug addition, gas, temperature, media and more, this all in one system is the perfect addition to your microscope to enhance your imaging…
9 March 2016 | By Victoria White
Researchers from the University of Texas at San Antonio have developed the "in silico" testing system for drugs in the early stage of drug development...
4 March 2016 | By Oxford Global
This upcoming webinars hosted by Oxford Global will provide an insight on Drug Discovery & Antibody Research...
29 February 2016 | By Victoria White
ProTx-II, a peptide toxin found within the venom of the Peruvian green velvet tarantula, has a high potency and selectivity to inhibit the pain sensation receptor...
15 February 2016 | By Victoria White
Researchers say drug discovery processes are becoming unsustainably expensive despite huge technological advances because the wrong methods are being used…
9 February 2016 | By Dr Bissan Al-Lazikani and Elizabeth Coker, The Institute of Cancer Research, London
Dr Bissan Al-Lazikani and Elizabeth Coker discuss canSAR: the first public domain example of Big Data for drug discovery...